Cns Pharmaceuticals (BE50.F) Q4 2025 Earnings

Nov 14Confirmed
Q1 1
Q2 2025
Q3 2025
Q4 2025
-21.45
-15.58
-9.72
-3.86

Details

Expected EPS
-5.7037889999999996
Actual EPS
-4.955328
Surprise EPS
0.75
Surprise Percent
+13.12%

Description

⁨Cns Pharmaceuticals⁩ (⁦BE50.F⁩) has reported earnings of ⁦-4.955328⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts